Search Conferences

Type in any word, words or author name. This searchs through the abstract title, keywords and abstract text and authors. You may search all conferences or just select one conference.


 All Conferences
 EMAC 2025 Fall Conference
 EMAC 2025 Spring Conference
 EMAC 2024 Fall Conference
 EMAC 2024 Spring Conference
 EMAC 2023 Regional Conference
 EMAC 2023 Annual Conference
 EMAC 2022 Regional Conference
 EMAC 2022 Annual Conference
 EMAC 2021 Regional Conference
 EMAC 2021 Annual Conference
 EMAC 2020 Regional Conference
 EMAC 2020 Annual Conference
 EMAC 2019 Annual Conference

EMAC 2025 Fall Conference


RECALLS OF INNOVATIVE PRODUCTS AND FIRM MARKET VALUE AND FIRM STOCK RISK
(A2025-130463)

Published: September 24, 2025

AUTHORS

Ismail Erzurumlu, NEOMA BS; NUKHET HARMANCIOGLU, Koc University

ABSTRACT

This study examines the effects of innovative products’ recalls on both short- and longterm stock returns and firm unsystematic equity risk. Drawing upon signaling theory, we argue that specific recall (i.e., recall time, recall volume, recall severity, and recall initiator) and innovation characteristics (i.e., innovative product’s life and innovation type) influence firm market value and unsystematic equity risk due to recalls of innovative products. The results of a sample of 232 recalls of innovative products show that equity holders punish the recalling firms in the short and long-term. Recall volume negatively influences stock market returns in the short-term. Recall severity exerted a negative effect in the short-term; however, the effect switched to positive in the longterm. Moreover, voluntary recalls have no impact on short-term abnormal stock returns; however, they lead to lower stock market returns in the long term compared to involuntary recalls of innovative products. Innovation type positively affects the stock market returns in the short-term. Recall volume and severity are positively associated with increases in unsystematic risk, while innovative product’s life reduces unsystematic risk.